BCRX vs MSFT: Which Stock is Better?
Side-by-side comparison of BioCryst Pharmaceuticals Inc and Microsoft Corporation in 2026
BCRX
BioCryst Pharmaceuticals Inc
$10.05
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | BCRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.83B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | BCRX |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 36.1% | 18.4% | BCRX |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze BCRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BCRX or MSFT a better investment?
Comparing BCRX and MSFT: BioCryst Pharmaceuticals Inc has a market cap of $1.83B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BCRX and MSFT?
BCRX (BioCryst Pharmaceuticals Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BCRX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BCRX or MSFT?
BCRX has higher revenue growth at 36.1% vs 18.4% for MSFT.
Which company is more profitable: BCRX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for BCRX.
Which is the larger company: BCRX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.83B for BCRX.
Should I buy BCRX or MSFT in 2026?
Both BCRX and MSFT have investment merit. BCRX trades at $10.05 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BCRX and MSFT stock?
Key differences: Market Cap ($1.83B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (36.1% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy BCRX or MSFT in 2026?
The choice between BCRX and MSFT depends on your investment goals. BCRX shows higher revenue growth (36.1%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between BCRX and MSFT?
BCRX (BioCryst Pharmaceuticals Inc) has a market cap of $1.83B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.